The information on this page is intended for journalists, press and media. Click YES to get to the newsroom. If you click NO you will come back to Mynewsdesk.com.
Under external magnetic field, circularly polarized luminescence (CPL) was successfully generated from achiral platinum complexes at room temperature. Expected to reduce manufacturing costs of organic EL panels for 3D display, and practical applications for advanced next-generation security/authentication technologies.
- Measures serum core-type fucosylated PSA, which was not possible in the past, with high speed and high sensitivity - Verified that fucosylated PSA index significantly rises in a man with high-risk prostate cancer - Adjunct in the conventional PSA test, high-risk prostate cancer can be effectively detected
- Discovered for the first time in the world that Stress Granules (SGs) have the role of a "safety brake" that regulates signaling pathways that control cell proliferation, such as Protein Kinase C (PKC) and Mitogen-Activated Protein Kinase (MAPK). - SGs have the function of preventing excessive activation of MAPK by incorporating PKC.
- Elucidation of the mechanism of the compound "ACA-28" that selectively induces cell death in cancer cells - ACA-28 induces cell death of cancer cells and inhibits the growth by destroying tumor suppressor factors. - Expectations for the development of anticancer drugs with less side effects that target brakes instead of accelerators for cancer cells
Kindai University’s Faculty of Medicine has, in a world first, shown the efficacy of cancer-specific vaccine therapy as a postoperative adjuvant therapy in a phase 2 clinical trial. Administration of cancer-specific vaccine therapy roughly doubled the 5-year survival rate of advanced esophageal cancer patients. Vaccine therapy amplifying CTL2 is expected to help validate peptide vaccine therapy.
This research is expected to contribute to the development of reproductive medicine, including human infertility treatment, and animal breeding technology through practical application of the special characteristics of fertilized eggs that were discovered.
- Introduction of Slack aims to build a new communication platform for staff and students institution wide - Utilization of Slack enhances the effectiveness of distance learning solutions - Expansion of student support through user-friendly Slack
- Efficacy of molecular target drug Nivolumab verified in investigator-initiated clinical trial for use with CUP by hospital team from Kindai University’s Faculty of Medicine - Reductions by more than half in tumor size in over 20% of CUP patients observed - Nivolumab expected to become standard treatment for CUP cases with no standard treatment
Astronomers obtained the first resolved image of disturbed gaseous clouds in a galaxy 11 billion light years away by using ALMA. The team found that the disruption is caused by young powerful jets ejected from a supermassive black hole residing at the center of the host galaxy. This result will cast light on the mystery of the evolutionary process of galaxies in the early Universe.
The research team from Kindai University's Faculty of Medicine, in cooperation with DAIICHI SANKYO COMPANY, LIMITED, have verified at the preclinical stage that using the currently under-development anti-cancer drug, U3-1402*1, in combination with immune checkpoint inhibitors*2 has the potential to be an effective treatment.
Kindai University and Teikyo University have cooperated on an overseas internship program in Ho Chi Minh City in Vietnam. Students worked on developing new markets for "Gokiburi Hoi Hoi" (Earth Cooperation) through a problem solving project-based learning program. After returning to Japan, the students will give a presentation of their marketing strategies to the CEO of Earth Cooperation.
Senior Administrator Masatoshi Kudo of Kindai University Faculty of Medicine, Department of Gastroenterology and Hepatology, with his research group has invented a new method (LEN-TACE) of treating patients with intractable multinodular or large liver cancers, particularly those with near advanced liver cancer.
When you choose to create a user account and follow a newsroom your personal data will be used by us and the owner of the newsroom, for you to receive news and updates according to your subscription settings.
To learn more about this, please read our Privacy Policy Users, which applies to our use of your personal data, and our Privacy Policy Contacts, which applies to the use of your personal data by the owner of the newsroom you follow.
Please note that our Terms of Use apply to all use of our services.
You can withdraw your consent at any time by unsubscribing or deleting your account
Email sent to __email__. Click the link there to follow Japan University News.